ClinTrial Refer is pleased to welcome PASO Medical to the ClinTrial Refer community!

Sanjiv Gambhir had an ingenious solution to an age-old problem in the fight against cancer. He never said it would be easy.

Thanks to a significant donation from PASO Medical, Monash Health Pathology is now able to sequence chromosomes at a substantially larger scale.

The MK-3475-057 study is a Phase II Clinical Trial for Bladder Cancer. This trial targets patients with High Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy.

Advanced Solid Tumour Study – Preliminary Efficacy Results Are Promising – ASCO 2019

The ENZAMET Trial results were presented at the ASCO Annual Meeting (the world’s largest oncology conference). ENZAMET was one of 4 clinical trials chosen for presentation at the Plenary (Main) Session at the ASCO Conference on 3/6/19 (out of 3500 abstracts).

Melbourne oncologist A/Prof Vinod Ganju explains what you can do to help those living with cancer.

Peninsula & Southeast Haematology and Oncology Research Group have commenced the Odonate Therapeutics Inc research study of the new anti-cancer drug, tesetaxel, as a possible treatment for human epidermal growth factor receptor 2 (HER2) negative, hormone receptor (HR) positive breast cancer that is locally advanced or spread to one or more body parts.